Wednesday - April 29, 2026

Oral Complement Factor D Inhibitors

2026-02-24

ALEXANDRIA, Virginia, Feb. 24 -- BIOCRYST PHARMACEUTICALS, INC., Durham, North Carolina has been assigned a patent (No. US 12558341 B2, initially filed Oct. 9, 2020) developed by eight inventors Pravin L. Kotian, Hoover, Alabama; Yarlagadda S. Babu, Birmingham, Alabama; Weihe Zhang, Vestavia Hills, Alabama; Peng-Cheng Lu, Vestavia Hills, Alabama; Andrew E. Spaulding, Hoover, Alabama; Wei Lv, Hoover, Alabama; Zhao Dang, Vestavia Hills, Alabama; and Krishnan Raman, Birmingham, Alabama, for "Oral . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Oral Complement Factor D Inhibitors

Information Request Form

Copyright Targeted News Service 2026